Tritium-labeled cholesterol has been fed to a selected series of patients to demonstrate a quantitative metabolic defect in lipid metabolism in the presence of abnormal serum lipoprotein spectra. Patients with abnormal serum lipoprotein spectra carry a greater fraction of their newly absorbed cholesterol in the esterified form than do normals.
THE LIPOPROTEINS of human serum are conveniently defined and quantitated in the ultracentrifuge according to their flotation rates under carefully defined conditions.' Inasmuch as the concentration of certain serum lipoprotein molecules so defined (Sf 12-20; Sf 20-100*) show a positive correlation with the incidence of human atherosclerosis,2 those factors which determine the lipoprotein spectrum of the serum in any individual become of potential importance in understanding the pathologic physiology of atherosclerosis. A search for determining factors important in lipoprotein metabolism logically includes several varied aspects of cholesterol metabolism. The interrelationships between serum lipoprotein spectra and oral cholesterol metabolism are under investigation in this study. Labeled cholesterol has been administrated to a series of 10 patients, and it has been possible to demonstrate a quantitative metabolic defect in lipid metabolism in patients who have abnormal ultracentrifugal lipoprotein spectra.
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This work was supported in part by the U. S. Atomic Energy Commission. * Units are Svedbergs of flotation (Sf). One Sf unit equals a migration rate of 10-1' cm./sec./dyne/ Gm. at 26 C. in a medium of sodium chloride solution of density 1.063. 393 Tritium-labeled cholesterol' has been fed to 10 selected patients: two with xanthoma tuberosum, two with xanthoma tendinosum, three with clinical atherosclerosis, and three normals. Patients with xanthomata have been used in four instances because they afford a unique opportunity to study extremes in lipoprotein spectra. 4 Patients with xanthoma tuberosum have elevated serum cholesterol values associated with an extremely abnormal ultracentrifuge pattern; the lipoprotein spectrum approaches that seen in cholesterol-fed rabbits. In xanthoma tendinosum, on the other hand, there is also a hypercholesterolemia but here the ultracentrifuge lipoprotein spectrum is of particular interest in that the hyperlipoproteinemia remains almost entirely within the Sf 0-12 class of lipoprotein molecules. The 10 patients selected then afford a sampling over a wide range of lipoprotein spectra. Besides providing a wide range of serum lipoprotein spectra the patients also provide wide variations in serum cholesterol values as well. Within the 10 patients of the group, however, there is no correlation between the level of serum cholesterol and the type of centrifuge pattern found. As a result it has been possible to evaluate independently the quantitative metabolic differences in lipid metabolism observed in the various individuals with respect to the absolute serum cholesterol level and also with respect to the concentrations of various lipoprotein molecules.
EXPERIMENTAL PROCEDURE A single dose of tritium-labeled cholesterol, between 0.55 and 0.77 mc., was administered to each Circulation, Volume VII, March, 1953 patient at the beginning of the experiment. The cholesterol, average dose = 0.63 Gm., was dissolved in 15 cc. of warm Wesson oil and emulsified into 200 cc. of whole milk together with 60 Gm. of ice cream. After the ingestion of this labeled fatty meal, periodic blood samples were obtained, and the serum free and total cholesterol specific activities were determined. The cholesterol in each serum sample was precipitated as the digitonide which in turn was combusted for tritium activity determinations as previously described.5 The experiment was done on an out-patient basis and the patients ate their "regular diets" at home. Just prior to administering the tritium cholesterol a blood sample was taken for ultracentrifugal analysis of the serum lipoprotein spectrum. Three serum cholesterol determinations were made on each patient according to the method of Schoenheimer-Sperry6 as modified by Colman.7 These de-to the concentration of Sf 12-20 molecules. The shaded area in frame 2 is the area read for Sf 20-100 molecules. The concentration of Sf 0-12 molecules has been taken from frame 5; the concentration of Sf 100-400 molecules from frame 1.* Beneath each ultracentrifuge plate is the corresponding cholesterol specific activity absorption curve for that patient. Here the free cholesterol specific activities and the total cholesterol specific activities have been plotted as a function of time in days. The abscissa is broken at the right to include specific activity determinations over a several weeks period.
Identification of the patient together with certain pertinent information such as the terminations were done at approximately weekly intervals usually on the serum of days 1, 7 and 14 following the start of the experiment.
RESULTS
For the sake of clarity the experimental results are presented in graphic form in figures 1 through 10. An ultracentrifugal analysis of the lipoprotein spectrum of the serum of each patient at the beginning of the experiment tops each figure. The concentration of lipoprotein molecules, Sf 0-12, Sf 12-20, Sf 20-100 and Sf 100-400, read from each plate, is included in the legend. It should be noted that the ultracentrifuge plates were not made at the same serum concentration in each case; the fold concentration is included for each. The shaded area in frame 5 of each plate is proportional tritium-cholesterol dosage is included in the legend.
The serum cholesterol values are included in table 1. DISCUSSION Examination of the 10 cholesterol specificactivity absorption curves shows a quantitative difference in the way various individuals handle oral cholesterol with respect to its partition after absorption into the free and esterified pools of serum cholesterol. Patient 1, after 24 hours, shows a free serum cholesterol specific activity 2.19 times as great as the total serum * The method of plate reading employed in this laboratory has been developed by Dr. John Gofman and will be reported in detail elsewhere. cholesterol specific activity; while patient 10, after 24 hours, shows a free serum cholesterol specific activity only 0.52 times as great as the total serum cholesterol specific activity. The remaining eight patients lie distributed between these two extremes. Ultracentrifugal analyses of the lipoprotein spectra of several thousands of "normal" young men and women show that the normal lipoprotein spectrum consists of a moderate or high concentration of Sf 0-12 molecules, with only low concentrations of molecules with greater flotation rates than this (Sf 12-20; Sf 20-100; Sf 100-400). In the following discussion Sf 0-12 molecules are treated as normal; Sf 12-400 molecules as abnormal.
A qualitative comparison of the cholesterol specific activity absorption curves with the ultracentrifuge plates in each case shows that those patients with a "normal or nearly normal" lipoprotein spectrum, with the bulk of their lipoprotein molecules in the Sf 0-12 class, have a cholesterol specific activity absorption curve wherein the free cholesterol specific activity is greater than the esterified cholesterol specific activity during active absorption of the tritium-cholesterol dosage. On the contrary those patients with a "moderately or grossly abnormal" lipoprotein spectrum with high concentrations of Sf 12-400 molecules do not show this relationship, but rather the abnormal centrifuge plates accompany cholesterol specific activity absorption curves wherein the free cholesterol is lower than or equal to the esterified cholesterol specific activity.
To correlate the cholesterol specific activity absorption curves against the total serum cholesterol and against the concentrations of various lipoprotein molecules it has been necessary to transpose the cholesterol specific activity absorption curves into some numeric evaluation. For this purpose the ratio of the free cholesterol specific, activity over the total cholesterol specific activity at 24 hours has been used. From the qualitative characteristics of the centrifuge plates and the cholesterol specific activity absorption curves (figs. 1 to 10) it is seen that when normal molecules (Sf 0-l 2) predominate the free cholesterol specific activity at 24 hours is greater than the total cholesterol specific activity. When abnormal molecules predominate (Sf 12-400) the esterified cholesterol has the greater specific activity.
In table 2 the ratio of free cholesterol specific activity over total cholesterol specific activity, the ratio of normal Sf 0-12 molecules over abnormal Sf 12-400 molecules, and the total serum cholesterol values are listed for each patient. Calculation of Pearson's productmoment coefficient of correlation between the ratio of free cholesterol specific activity over total cholesterol specific activity and the ratio of normal molecules (Sf 0-12) over abnormal molecules (Sf 12-400) gives a value of +0.93 (0.765 is significant at 1 per cent level). Calculation of the same correlation coefficient for the ratio of free cholesterol specific activity over total cholesterol specific activity and the total serum cholesterol values in milligrams per 100 cc. gives a value of +0.39 which cannot be proven significant from these data.
Thus the cholesterol specific activity absorption curves during the period of active tracercholesterol absorption show a positive correlation with the lipoprotein spectrum; however, from the data they cannot be correlated in significant fashion with the total serum cholesterol values in the same individuals. This positive correlation of the cholesterol specific activity absorption curves with the lipoprotein spectra and the failure of a significant correlation with the total serum cholesterol is interpreted as indicating that an ultracentrifugal analysis of the serum lipoprotein spectrum evaluates a metabolic defect in lipid metabolism which may be completely independent of the total serum cholesterol values.
Warner8 reported in his observations on the metabolism of tracer cholesterol following oral ingestion that in dogs and terminal patients the free cholesterol specific activity is greater than the esterified cholesterol specific activity during the period of active absorption. We have previously observed that rabbits do not handle oral cholesterol in similar fashion but rather show a higher cholesterol ester specific activity than free cholesterol specific activity.9
These observations are entirely consistent inasmuch as dogs aid many terminal patients show what would be classified as a normal or nearly normal lipoprotein spectrum. Rabbits on the other hand show an abnormal lipoprotein picture after cholesterol feedings. Dogs do not get atherosclerosis from cholesterol feedings alone; rabbits do. Just how applicable observations made in rabbit atherosclerosis are to the human disease is still under debate; however, as time passes, more and more observations on lipid metabolism in the rabbit are proving to have a parallelism in the "atherogenic" man. It has been demonstrated in both rabbits and man that exogenous cholesterol is only partially absorbed; however, once absorbed, that it mixes with the metabolic cholesterol pools of the serum and tissues including aorta.9' 10 It has been demonstrated that the cholesterol fed makes up the bulk of the atheromatous cholesterol deposits in the aorta in experimental atherosclerosis.'0 Ultracentrifugal lipoprotein spectra of varying degrees of abnormality are to be found in humans and many patterns closely simulate those seen in the atherosclerotic rabbit (patients 8, 9 and 10) .
It has now been demonstrated that those patients with abnormal lipoprotein spectra handle oral cholesterol with respect to its partition after absorption into the serum free and esterified cholesterol pools, in an abnormal fashion;
in a fashion identical with that seen in the rabbit. At this point it must be emphasized that the fundamental abnormality producing the variations in the cholesterol specific activity absorption curves observed in the patients in this study remains obscure. The problem assuredly concerns cholesterol ester metabolism, but whether the defect is in the metabolism of esterified cholesterol as a unit (that is, altered cholesterol esterase activity), or in the metabolism of one of its component parts, cholesterol and/or fatty acid, is not known. That the defect in metabolism involves cholesterol plus fatty acid in an esterified form is of additional interest in view of the fact that dietary alteration of the serum lipoprotein spectrum is most effective upon co-reduction of fat and cholesterol in the diet.
Until the various fundamental aspects of lipid metabolism are clarified and a more direct attack on the problem can be made, the bulk of evidence at hand supports the belief that judicious control of dietary fat and cholesterol as a prophylactic measure in patients with abnormal lipoprotein spectra is worth while. Such treatment would appear particularly indicated in patients such as 8, 9 and 10. Finally it may be added that the data adds further evidence to that of McGinley and Gofman4 that the diseases classified as xanthoma tuberosum and xanthoma tendinosum, although they have a hyperlipoproteinemia in common, probably are caused by entirely different fundamental metabolic defects.
SUMMARY
Tritium-labeled cholesterol has been used in a selected series of patients to demonstrate a quantitative metabolic defect in lipid metabolism in the presence of abnormal serum lipoprotein spectra. This metabolic defect involves the partition of oral cholesterol into the free and esterified cholesterol pools of the serum. Patients with abnormal serum lipoprotein spectra carry a greater proportion of their newly absorbed cholesterol in the esterified form than do normals.
The different cholesterol specific activity absorption curves found correlate with the ABNORMAL SERUM LIPOPROTEIN5 serum lipoprotein distribution as demonstrated with the ultracentrifuge; but the absorption curves do not correlate with the total serum cholesterol values found. Thus ultracentrifugal analysis of the serum lipoproteins measures a metabolic defect in lipid metabolism which can be independent of the total serum cholesterol present.
Past observations made in rabbits and dogs are consistent with the present observations in man. Cholesterol fed rabbits have abnormal cholesterol specific activity absorption curves and abnormal lipoprotein spectra. Cholesterol fed dogs have a normal absorption curve associated with a normal lipoprotein spectrum. Rabbits become atherosclerotic on cholesterol feedings alone; dogs do not.
This study appears to implicate dietary fat and cholesterol as a secondary factor in atherogenesis more strongly than before.
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SUMARIO ESPAROL
Colesterol rotulado con tritium se le ha administrado por via oral a una serie de pacientes seleccionados para demostrar un defecto cuantitativo metabolico en la presencia de espectros anormales de las lipoproteinas del suero. Pacientes con espectros anormales de las lipoproteinas del suero cargan una fraccion mayor del colesterol absorbido recientemente en la forma esterificada que los sujetos normales.
